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Abstract
Foot-and-mouth disease (FMD) is a trans-boundary viral disease of livestock, which causes huge economic losses and
constitutes a serious infectious threat for livestock farming worldwide. Early diagnosis of FMD helps to diminish its impact
by adequate outbreak management. In this study, we describe the development of a real-time reverse transcription
recombinase polymerase amplification (RT-RPA) assay for the detection of FMD virus (FMDV). The FMDV RT-RPA design
targeted the 3D gene of FMDV and a 260 nt molecular RNA standard was used for assay validation. The RT-RPA assay was
fast (4–10 minutes) and the analytical sensitivity was determined at 1436 RNA molecules detected by probit regression
analysis. The FMDV RT-RPA assay detected RNA prepared from all seven FMDV serotypes but did not detect classical swine
fever virus or swine vesicular disease virus. The FMDV RT-RPA assay was used in the field during the recent FMD outbreak in
Egypt. In clinical samples, reverse transcription polymerase chain reaction (RT-PCR) and RT-RPA showed a diagnostic
sensitivity of 100% and 98%, respectively. In conclusion, FMDV RT-RPA was quicker and much easier to handle in the field
than real-time RT-PCR. Thus RT-RPA could be easily implemented to perform diagnostics at quarantine stations or farms for
rapid spot-of-infection detection.
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Introduction
FMD is a contagious trans-boundary disease infecting cloven-
hoofed animals and leads to huge economic losses (death of young
ruminants, diminishes milk, and meat production) [1]. FMDV is a
non-enveloped, positive sense single stranded RNA virus belong-
ing to the genus Aphthovirus of the Picornaviridae family [2]. It has
seven serotypes (A, O, C, SAT 1-3, and Asia1) that have a distinct
geographical distribution (A and O are widely distributed across
the world, SAT 1-3 mainly in Africa and Asia 1 in Asia) [3].
Europe and North America are free of FMDV. Nevertheless, to
date no country is considered safe [4]. There is always a fear of
introducing FMDV into a FMDV-free country or a new serotype
into a FMDV-endemic country. For example serotype O was
endemic in Egypt since 1960 [5], and in 2006, type A was
introduced and caused a FMD outbreak [6]. Recently, SAT 2 was
the primary cause of a FMD epidemic in Egypt which erupted in
February 2012 and led to 82362 suspected cases, of which 19655
died [7]. Outbreaks due to SAT 2 were also reported from Libya
and the Gaza strip [8,9]. It is assumed that FMDV SAT2 was
introduced from sub-Saharan Africa where it is endemic [9].
FMDV is highly contagious due to the ability of the causative
agent to gain entry and initiate infection via a variety of sites, the
small infective dose, the short incubation period, and the release of
FMDV before the onset of clinical signs. In addition, the massive
quantities of virus excreted from infected animals, its ability to
spread large distances due to airborne dispersal and the
survivability of the virus in the environment contribute to its
contagiousness [10]. It is therefore absolutely necessary to detect a
FMD outbreaks as early as possible to initiate the appropriate
control measures and prevent further spread among livestock. As
other diseases may cause clinical signs resembling FMD, often a
laboratory confirmation of suspect cases is indispensible. The
classical method, virus isolation takes several days and is only
possible in a few specialized laboratories. Lateral flow assays [11]
and antigen ELISA have a limited sensitivity and yield positive
results only with vesicular material but not with saliva, nasal swabs
or serum [4]. Currently, laboratory diagnosis of FMD mostly
depends on the detection of viral RNA by reverse transcription
polymerase chain reaction (RT-PCR) [12–14]. Samples collected
from animals in the field or at quarantine stations are sent to
central laboratories for testing, as RT-PCR assays are not suitable
for on-site screening. Therefore, portable, accurate, simple, and
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rapid tests are needed to detect the virus at the spot-of-infection.
Recombinase polymerase amplification (RPA) is an isothermal
DNA amplification and detection method [15]. The amplification
depends on a specific combination of enzymes and proteins
(recombinase, single strand binding protein, and strand displacing
DNA polymerase) used at a constant temperature. Real-time
detection of RPA amplicons is possible via exo-probes. Develop-
ment of fluorescence depends on the separation of fluorophore and
quencher via Exonuclease III cleaving at an internal abasic site
mimic (tetrahydrofuran, THF) of the hybridized exo-probe
[16,17]. The fluorescence signal is measured in real-time via a
simple point-of-care scanner weighing 1.2 kg including the laptop
(ESEQuant Tubescanner device, Qiagen Lake Constance GmbH,
Stockach, Germany). This study describes the development of a
real-time reverse transcription RPA (RT-RPA) assay for the
detection of all FMDV serotypes and its use in the 2012 FMD
outbreak in Egypt.
Materials and Methods
Ethics Statement
Twenty-seven samples (Table 1) were derived from two animal
trial (#FLI 007/08 and #FLI 002/11) performed at the
Friedrich-Loeffler-Institute, Greifswald-Insel Riems, Germany.
The two experiments were licensed by the Landesamt fu¨r
Landwirtschaft, Lebensmittelsicherheit und Fischerei Mecklen-
burg-Vorpommern, Thierfelder Str. 18, 18059 Rostock, Germany
with following animal welfare license numbers LALLF M-V/
TSD/7221.3-1.1-017/08 and LALLF 7221.3-2.5-002/11.
Viruses
All FMDV reference strains used in this study were provided by
the World Reference Laboratory for FMDV, Pirbright, UK.
FMDV serotype A vaccinal strain (A Argentina 2001) was used to
prepare the RNA molecular standard. The following FMDV
strains were used for the assay validation: O Manisa, O BFS 1860,
O TUR28/2011, O TUR33/2011, A24 Cruzeiro, A22 Iraq 24/
64, A TUR 29/2011, A TUR64/2011, A BAR18/2011, C
Oberbayern, C Noville, Asia1 Shamir, Asia TUR49/2011, Asia
TUR51/2011, Asia TUR 65/2011, Asia PAK 5/2012, SAT1
Zimb22/89, SAT2 Egypt 2/2012, SAT2 Egypt 6/2012, SAT2
Libya 40/2012, and SAT3 Zim4/81. Also Swine vesicular disease
virus (SVDV ITL/7/07, SVDV ITL/8/07) had been sent to the
Friedrich-Loeffler-Institute by the Pirbright Institute, Pirbirght,
UK. Classical swine fever virus (CSF) (Koslov genotype 1.1) was
provided by the German national reference laboratory for CSF,
Friedrich-Loeffler-Institute, Greifswald-Insel Riems, Germany.
Generation of RNA Standard
The FMDV serotype A RNA was reverse transcribed and
amplified using the QIAGEN OneStep RT-PCR kit (Qiagen,
Hilden, Germany). The forward primer: 59-CACTTCCACATG-
GATTATGGAACTG-39, and the reverse primer: 59-ACATCT-
GAGGGATTATGCGTCAC-39 were used to amplify 260 nt of
the highly conserved RNA polymerase (3D) gene of FMDV (7839–
8098 nt of Genbank accession number JF749843) [13]. The RT-
PCR reaction was set as follows: RT step 50uC/30 minutes, initial
activation at 95uC/15 minutes, 30 cycles of 94uC/30 seconds,
58uC/60 seconds, and 72uC/60 seconds, and a final extension step
of 72uC/10 minutes. The amplified fragment was ligated into
pCRHII using the TA-cloning kit dual promoter with One shotH
chemically competent E.coli (Invitrogen, Darmstadt, Germany).
The ligated fragment was confirmed by sequencing (Seqlab,
Goettingen, Germany) and the RNA was transcribed and
quantified as previously described [18]. The standard was tested
by a published real-time RT-PCR protocol [13] using the Light
Cycler 2.0 and the LightCycler 480 RNA Master Hydrolysis
Probes kit (Roche, Manheim, Germany).
Real-time RT-RPA Primers and Exo-probes
Nineteen forward primers, 20 reverse primers, and 4 exo-probes
(Figure 1 and Figure S1 in File S1) were used to determine the
combination yielding the highest RT-RPA assay sensitivity. They
were designed using the available sequences of the FMDV 3D
gene (Genbank accession numbers AF536538.1, GQ294636.1,
EU400597.1, NC_004004.1, AY593830.1, DQ404158.1,
EF552689.1) and were synthesized by TIB MOLBIOL (Berlin,
Germany).
RT-RPA Conditions
The FMDV RT-RPA was performed in the laboratory in a
50 ml volume using the TwistAmpTM exo lyophilized kit (TwistDx,
Cambridge, UK) and addition of reverse transcriptase (RT)
‘Transcriptor’ (Roche, Mannheim, Germany). 420 nM RPA
primers, 120 nM RPA exo-probe, 10 U RT ‘Transcriptor’
(Roche, Mannheim, Germany), 20 U RiboLock RNase inhibitor
(Fisher, Schwerte, Germany), 2 mM DTT (Roche), 14 mM Mg
acetate, 4x TwistAmpTM rehydration buffer (TwistDx), and 1 ml
RNA template were added to the RPA strips containing a dried
enzyme pellet as described [16]. Fluorescence detection in the
FAM channel (excitation 470 nm and detection 520 nm) was
performed in an ESEQuant tubescanner (Qiagen Lake Constance
GmbH, Stockach, Germany) at 42uC for 20 minutes. A combined
threshold and signal slope analysis confirmed by 2nd derivative
analysis offered by the tubescanner software was used for signal
interpretation. In the field during the FMD 2012 outbreak in
Egypt, the real-time RT-RPA assay was carried out using the
TwistAmpTM RT exo (TwistDx, Cambridge, UK) according to
the following formula: 420 nM RPA primers, 120 nM RPA exo-
probe, 14 mM Mg acetate, 4x TwistAmpTM rehydration buffer
(TwistDx), and 5 ml RNA template.
Analytical Sensitivity
The analytical sensitivity of the RT-RPA assay was tested using
a dilution range from 107 to 101 molecules/ml of the FMDV RNA
standard in 8 replicates, the threshold time was plotted against
molecules detected and a semi-log regression was calculated using
Prism software (Graphpad Software Inc., San Diego, California).
In addition, a probit regression was performed using the Statistica
software (StatSoft, Hamburg, Germany).
Specificity
The specificity of the FMDV RT-RPA assay was determined by
testing twenty-one RNA preparations from the seven FMDV
serotypes (listed above), and twelve FMDV-PCR-negative samples
(saliva, serum, milk) from apparently healthy cows provided by the
Animal Health Research Institute, Giza, Egypt. In addition, RNA
of classical swine fever and swine vesicular disease viruses was
screened for cross reactivity.
Clinical Samples
Twenty-seven samples (Table 1) including vesicular material,
saliva, serum, blood, and swabs from FMDV-immunization
experiments performed at the Friedrich-Loeffler-Institute, Greifs-
wald-Insel Riems, Germany were used to test the performance of
the RT-RPA assay. The results were compared to real-time RT-
PCR results.
Point-Of-Entrance System for the Detection of FMDV
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A mobile RT-RPA unit was operated in Giza and Faiyum,
Egypt between April 22nd–25th 2012 during the FMD outbreak.
A total of 45 samples (heart, blood, serum, milk, saliva, and
vesicular materials) from cattle, buffalo, and sheep were collected
by the General Organization for Veterinary Services, Giza, Egypt
according to the Egyptian Animal Welfare Act and all relevant
institutional guidelines. The RNA was extracted using the
DynabeadsH Silane viral nucleic acid (Invitrogen, Darmstadt,
Germany) according to the manufacturer instructions. Then the
FMDV RT-RPA was performed using the ready-to-use Twis-
tAmpTM exo RT kits (TwistDx, Cambridge, UK) [16]. Real-time
RT-PCR and FMDV serotyping of the samples was performed at
the Animal Health Research Institute, Giza, Egypt as described
[8]. In addition, the same samples were also tested by real-time
RT-PCR and RT-RPA at the Virology Department in Goettin-
gen. The R squared of the real–time RT-PCR cycle threshold and
the real-time RT-RPA threshold time of clinical samples was
calculated using linear regression analysis (Prism software,
Graphpad Software Inc., San Diego, California).
Real-time RT-PCR
At the Friedrich-Loeffler-Institute, Greifswald-Insel Riems,
Germany, a Bio-Rad CFX 96 Real-Time Detection System was
used in combination with the 3D-region assay [13], which
amplifies a 88 bp fragment of the 3D region. The FMDV 3D
real-time PCR assay was carried out as published except that the
Superscript III One-Step RT system with Platinum Taq
polymerase (Invitrogen, Darmstadt, Germany) was used. At the
Virology Department, Goettingen, Germany, the same real-time
RT-PCR assay was performed using the LightCycler 480 RNA
Master Hydrolysis Probes kit on the Light Cycler 2.0. At the
Animal Health Research Institute, Giza, Egypt, the test was
performed as previously described [8].
Results
FMDV RT-RPA Assay Sensitivity and Specificity
An RNA standard representing 260 nt of the 3D gene of
FMDV was produced via in vitro transcription from a plasmid
containing a 3D gene fragment. A dilution range of 107-101
molecules/ml of the FMDV RNA standard was used to determine
the analytical sensitivity of the RT-RPA assay in comparison to a
real-time RT-PCR assay. To select a highly sensitive RT-RPA
assay, combinations of forward primers (F), reverse primers (R),
and exo-probes (P) listed in the Figure S1 in File S1 were tested.
The sensitivity of most of the combinations was very low (e.g. 105
molecules detected with F14+R19+P1). F04+R20+P2 yielded
analytical sensitivity of 102 RNA molecules detected (Figure 2)
and was used for further assay validation. The time required to
perform the assay to the limit of detection was 10 minutes
(Figure 3A). Additionally, a probit regression analysis was
performed using a data set of eight RT-RPA runs on the
molecular RNA standard. The limit of detection in 95% of cases
was 1436 RNA (Figure 3B). Interestingly, using an exo-probe
designed for the reverse complementary strand (P2, Figure 1 & 2)
yielded a better sensitivity than the positive sense exo-probe (P1,
Figure S1 in File S1). In an attempt to shorten the exo-probes, P3,
P4, synthesized with locked nucleic acid nucleotides (LNA) were
tested but showed a very low sensitivity of 105 RNA molecules
detected (Figure S2A in File S1) and non-specific detection (Figure
Figure 1. FMDV RT-RPA primers and exo-probe sequences aligned with the consensus sequence of 100 FMDV 3D genes
downloaded from the Genbank. (GeneiousH 6.1.5, Biomatters Limited, New Zealand). Mismatches are indicated in bold and underlined. The
consensus sequence represents nt 7847–7961 of FMDV sequence JF749843. NNN are sites of the quencher and fluropohore in following order (BHQ1-
dT) (Tetrahydrofuran) (FAM-dT). Y is C & T; R: A & G.
doi:10.1371/journal.pone.0071642.g001
Table 1. Detection of FMDV in experimentally infected
animals using real-time RT-PCR and RT-RPA.
Animal
ID Species Dpi Sample type Detection
RT-PCR
(CT)
RT-RPA
(minute)
P23 Pig1 3 Serum 29.37 neg
P24 Pig1 3 Serum 15.02 3.7
G50 Goat1 3 Serum 31.1 neg
G51 Goat1 5 Serum 22.55 5.3
S8 Sheep1 3 Blood 36.14 neg
S11 Sheep1 5 Blood 29.34 6.7
WB18 Wild boar2 5 Saliva 30.3 neg
WB18 Wild boar2 3 Nasal swabs 29.36 neg
WB18 Wild boar2 3 Serum 19.79 5.7
WB18 Wild boar2 4 Nasal swabs 26.31 6
WB18 Wild boar2 12 Vesicular material 23.71 6
WB19 Wild boar2 4 Nasal swabs 24.48 5.3
WB19 Wild boar2 8 Saliva 28.88 neg
WB19 Wild boar2 12 Vesicular material 19.2 5.3
WB20 Wild boar2 2 Serum 17.81 5.3
WB20 Wild boar2 3 Serum 15.37 5.3
WB20 Wild boar2 3 Nasal swabs 27.04 neg
WB20 Wild boar2 3 Saliva 19.43 6
WB20 Wild boar2 4 Nasal swabs 25.32 5.7
WB20 Wild boar2 12 Vesicular material 24.4 7
WB25 Wild boar2 12 Vesicular material 23.84 5.7
P165 Pig2 12 Vesicular material 18.57 5.3
P165 Pig2 3 Saliva 27.12 6.7
P165 Pig2 3 Serum 18.63 5.3
P165 Pig2 4 Saliva 27.64 5.7
P161 Pig2 4 Saliva 28.31 7
P161 Pig2 4 Serum 15.73 3.7
Dpi, days post infection;
1infected with serotype A22 Iraq 24/64;
2infected with O Bulgaria 2011; neg, negative.
doi:10.1371/journal.pone.0071642.t001
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S2B in File S1), respectively. To confirm sensitivity of the RT-RPA
assay, the RNA of twenty-one FMDV strains listed in material and
methods part representing all serotypes were screened and all were
detected (Figure S3 in File S1). In addition, unspecific amplifica-
tion or detection was not observed on twelve FMDV-free samples
from cows. No cross detections of the RNA of classical swine fever
virus and swine vesicular disease virus was observed.
Assay Performance on Clinical Samples
Twenty-seven samples encompassing vesicular materials, saliva,
serum, blood, and swabs were collected from animals immunized
with FMDV serotype A (A22 Iraq 24/64) and serotype O
(Bulgaria 2011). The total RNA extracts of each sample were
tested with both real-time RT-PCR and RT-RPA at the Friedrich-
Loeffler-Institute, Greifswald-Insel Riems, Germany. In compar-
ison to RT-PCR, the sensitivity of the RT-RPA assay was 74%
(n=27, Table 1). The real-time RT-PCR cycle threshold values
for the false negative samples in RT-RPA ranged from 27.04 –
31.1, and 36.14 (Table 1). Nevertheless, samples showing high
cycle threshold values up to 39 in real-time RT-PCR (see below,
Table S1 in File S1) indicating a very low molecular load were also
scored positive by RT-RPA. The presence of relevant sequence
variations was excluded because all FMDV strains were detected
by RT-RPA. Therefore, the false negative results might be due to
presence of inhibitors of the RT-RPA amplification and/or
detection phase.
During the FMD outbreak in Egypt (spring 2012), a mobile RT-
RPA unit was deployed. Forty-five samples were screened (Table
S1 in File S1). The total RNA extracted from each sample was
tested with real-time RT-PCR [8] (PCR-eg) and the RT-RPA
assay using the RT exo kit (RPA-Twist) at the Animal Health
Research Institute, Giza and the provincial laboratory Faiyum,
Egypt. Inactivated RNA extracts were also tested with real-time
RT-PCR [13] (PCR-de) and RT-RPA using the exo kits from
Twist DxTM in combination with RT ‘Transcriptor’ (Roche,
Mannheim, Germany) (RPA-Roche) at the virology Department,
Goettingen, Germany. The sensitivities of PCR-eg, PCR-de, RPA-
Twist, and RPA-Roche were 89, 100, 62, and 98% (n= 45),
respectively. RT-RPA using RT ‘Transcriptor’ was more sensitive
than RT-RPA using the MulV based RT-RPA kit (Twist DxTM).
A linear regression analysis of RPA-Roche threshold time and
PCR-de cycle threshold was performed. No correlation was found
between RT-PCR and RT-RPA values (R squared 0.26, Figure 4)
but samples showing high cycle threshold values in real-time RT-
PCR (e.g. 33.88 and 39.65, Table S1 in File S1) were also detected
by RT-RPA. A linear regression analysis of the cycle threshold
values of PCR-eg and PCR-de was calculated and R squared was
0.35 (Figure S4 in File S1).
Discussion
Currently, molecular methods to detect FMDV are mostly used
to confirm or rule out FMD in suspected cases. The only method
routinely employed is RT-PCR, usually in the form of a real-time
assay [13]. However, it is difficult to perform this test outside of a
well-equipped laboratory as real-time cyclers and even mobile
real-time cyclers are quite heavy, expensive, complex and must be
operated by qualified staff. In addition, test run times are usually
between 60–90 minutes. RT-PCR is therefore not suitable for
routine point-of-care detection of FMDV. However, there clearly
Figure 2. FMDV RT-RPA. Fluorescence development over time using a dilution range of 107-101 molecules/ml of the FMDV RNA standard (Graph
generated by ESEquant tubescanner software). F04+R20+P2 were employed and the analytical sensitivity was 102. 107 represented by black line; 106,
gray; 105, red; 104, blue; 103, green; 102, cyan; 101, dark khaki; negative control, orange.
doi:10.1371/journal.pone.0071642.g002
Point-Of-Entrance System for the Detection of FMDV
PLOS ONE | www.plosone.org 4 August 2013 | Volume 8 | Issue 8 | e71642
is a need for highly sensitive ‘‘pen-side’’ tests in the control of
infectious animal diseases [4]. Laboratories may be overwhelmed
by the number of samples in case of a large FMD epidemic. In any
case, it will at least take several hours until the official veterinarian
receives a laboratory result and thus may have to base his decision
to cull a holding on clinical signs in suspected cases. Unless an
FMD outbreak happens next to a well-equipped laboratory, only
fast and highly sensitive point-of-care detection will make it
feasible to cull confirmed FMDV positive animals in the
incubation phase, i.e. before they can infect many other
susceptible animals. In endemically infected countries, culling
usually is not feasible, but highly sensitive point-of-care assays
could contribute to FMD control by quickly providing a sound
scientific basis for decisions on animal movement restrictions. In
addition to confirm suspected clinical cases, it may make sense to
check animals for FMDV at border control posts or on livestock
markets. It is sometimes suggested to test also for persistent
infection, but FMDV excretion by persistently infected animals is
intermittent and thus even samples of optimal quality tested in a
highly sensitive real-time RT-PCR will miss many carrier animals.
Still, in some situations, e.g. if serological assays for antibodies to
(infection-induced) non-structural proteins of FMDV can not
resolve an unclear situation in a vaccinated population, herd
testing by point-of-care assays may help to detect persistent
infected animals. RT-RPA is carried out at a constant temperature
(42uC) and results are produced in maximum 15 minutes, on a
lightweight portable device (ESEQuant tubescanner). In this study
an RT-RPA assay for the detection of FMDV was developed.
A FMDV molecular standard based on the 3D gene was used to
determine the analytical sensitivity of the RT-RPA assay. Dozens
of primers and exo-probes (Figure S1 in File S1) were tested to
select an effective combination yielding a high sensitivity. Only the
combination F04 (34 nt, GC content 41.1), R20 (22 nt, CG
content 47.8) and P2 achieved a high analytical sensitivity (1436
RNA molecules detected, Figure 3B).
There are no clear-cut rules for the design of primers and exo-
probe other than the advice mentioned on the Twist Dx website
(http://www.twistdx.co.uk). Primers should be 30–35 nt in length,
not contain multiple Gs in the first 5 bp of the 59-end, and the GC
content should be between 40–60%. Interestingly, R20, which
yielded the highest RT-RPA sensitivity, is 22 nt in length, has two
Gs at the 59-end (Figure 1) and contains the lowest GC content of
all reverse primers used in this study (47.8%, Table S2 in File S1).
The RT-RPA primers were analyzed with Visual OMP (DNA
software, MI, USA) for secondary structure and to determine the
changes in the target secondary structure upon hybridization to
primers [19]. All primers formed folded secondary structures
(Figure S5 in File S1). In silico hybridization of the primers to the
target sequence induced secondary structure changes of the target
molecule (Figure S6 in File S1). Thus it appears that the successful
combination of primers and exo-probe exerted an influence on the
secondary structure of the target, which facilitated the RT-RPA
amplification and detection process whereas the unsuccessful
primers induced more complicated secondary structures not
amenable to the RT-RPA reaction (see Figure S6 B and C in
File S1).
According to exo-probe design rules, the exo-probe should be
placed into the positive sense strand, and consist of at least 30 nt to
the 59 and 15 nt to the 39 of the abasic site mimic. In contrast, P2,
yielding a RT-RPA sensitivity increased by one log10-step, was
designed complementary to the positive sense strand. It has 16 nt
59 and 32 nt 39 of the abasic site mimic and carries an inverse
arrangement of fluorophore and quencher.
Figure 3. Performance and analytical sensitivity of the FMDV
RT-RPA assay. A: Semi-logarithmic regression of the data collected
from eight FMDV RT-RPA test runs on the RNA standard using Prism
Software. It yielded results between 4–10 minutes. B: Probit regression
analysis using Statistica software on data of the eight runs. The limit of
detection at 95% probability (1436 RNA molecules) is depicted by a
triangle.
doi:10.1371/journal.pone.0071642.g003
Figure 4. Comparison between real-time RT-RPA and RT-PCR
for the detection of FMDV in clinical samples During Egypt
2012 FMD outbreak. Forty-five RNA extracts of samples collected
from suspected cases of FMDV were screened. Linear regression
analysis of RT-RPA threshold time (Y axis) and RT-PCR cycle threshold
values (X axis) were determined by Prism software. R squared value was
0.26.
doi:10.1371/journal.pone.0071642.g004
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The detection step in RT-RPA depends on the separation
between the fluorophore and its quencher via Exonuclease activity
which releases the shorter sequence containing the quencher [15].
Then the shorter sequence containing the quencher is released and
fluorescence is detected. In the approach recommended by Twist
DX, the long 59- part of the exo-probe and its non-protected 39
end could influence amplification by acting as a primer in
unwanted extension after release of the short 39-part of the exo-
probe. In contrast the short 16 nt 59-part of P2 is removed leaving
the hybridized long 32 nt phosphor group blocked 39-part of P2,
which therefore cannot be extended or otherwise interfere with
further amplification. To improve RT-RPA design it might be
necessary to consider this feature in exo-probe design in order to
reduce interference of the hybridized exo-probe section with
amplification. The same principle has been used in the design of
real-time PCR, TaqMan probes, which are blocked at their 39-end
to avoid the consumption of reactions component in unfavourable
probe extension [20].
The analytical sensitivity of the FMDV RT-RPA assay using
F04, R20 and P2 was 1436 RNA molecules as determined by
probit analysis of the results of eight assay runs (Figure 3B). The
analytical sensitivity of the published real-time RT-PCR was 10
RNA molecules detected [13]. Nevertheless, the diagnostic
sensitivity of the RT-RPA for the detection of FMDV during
the outbreak in Egypt was 98% (Table S1 in File S1). The lowest
titer of FMDV in the saliva of infected cows a few hours before
onset of clinical signs ranges from 102–103.75 TCID50/ml [21]. As
TCID50 readout depends on the presence of whole infective
virions and the particle-to-infectivity ratio is 1000/1 [22], it follows
that the detection limit of the RT-PPA assay is well in the range of
the presence of FMDV RNA in the saliva of infected cows, but
possibly not sufficient for virus detection in FMD carriers where
RNA titer is very low [23]. The RT-RPA assay detected all seven
FMDV serotypes, although primers and exo-probe cover an area
containing some mismatches among the various subtypes
(Figure 1). The maximum number of mismatches found within
one sequence was five (e.g. accession numbers AY593782.1,
HQ832584.1, and EU448374.1). In this case the length of primer
and exo-probe compensates for mismatches in the target sequence,
which usually cause real-time PCR small probes to fail or to lose
sensitivity [24]. In a recent study, up to nine mismatches within
RPA primers and exo-probe did not affect the HIV-1 RPA assay
performance [25]. The RT-RPA assay did not detect RNA of
other viruses causing vesicular diseases.
Recently, reverse transcription loop-mediated isothermal am-
plification (RT-LAMP) assays have been developed for rapid and
sensitive detection of FMDV [26–28]. In contrast to RT-RPA, six
primers are needed in RT-LAMP, which are difficult to design in a
highly variant virus like FMDV. In addition, RT-LAMP results
are produced within 45–60 minutes, while RT-RPA run time is
limited to 4–10 minutes.
In conclusion, the RT-RPA assay was developed for rapid and
sensitive identification of FMDV during outbreaks. Since RT-RPA
reagents are available in a dry pellet form and a battery-charged
portable instrument (ESEQuant tubescanner) can be used, the
FMDV RT-RPA assay is suitable for mobile testing at border posts
to monitor imported animals or for spot-of-infection screening in
FMD outbreaks.
Supporting Information
File S1 Figure S1, FMDV RT-RPA primers and probe
sequences. Nineteen forward primers (F), 4 probes (P), and 20
reverse primers (R) were tested to select combinations yielding the
highest analytical RPA sensitivity. NNN are sites of the quencher
and fluropohore in following order (BHQ1-dT) (Tetrahydrofuran)
(FAM-dT). LNA is probe containing locked nucleic acid (Bold and
underlined). RC is the reverse complementary of the original
sequence used in the experiment. Figure S2, The FMDV RT-RPA
sensitivity with probes containing LNA nucleotide. Fluorescence
development over time using a dilution range of 107-101
molecules/ml of the FMDV RNA standard (Graph generated by
ESEquant tubescanner software). A: F04+R20+P3 were used for
the amplification and detection steps and the sensitivity was 106.
107 represented by dot; 106, box; 105, triangular; 104, diamond;
103, star; 102, vertical-line; 101, horizontal-line; negative control,
plane line. B: grey line is control negative with F04+R20+P4;
black, F04+R20+P4+105 of FMDV molecular standard; red,
F04+R20+P2+105 of FMDV molecular standard; blue,
F04+R20+P3+105 of FMDV molecular standard. Figure S3,
The performance of the FMDV RT-RPA assay on RNA of
serotypes O (Manisa, orange; BFS, dark khaki), SAT1 (SAT1
Zimb22/89, magenta), SAT2 (SAT2 Egypt 6/2012, cyan), C (C
Oberbayern, black), and A (A22 Iraq 24/64, gray). Blue is the
positive control (synthetic FMDV RNA) and orange is the negative
control. Figure S4, Comparison between real-time PCR.eg and
PCR.de for the detection of FMDV in clinical samples During
Egypt 2012 FMD outbreak. Forty-five RNA extracts of samples
collected from suspected cases of FMDV were screened. Linear
regression analysis of cycle threshold (CT) values of PCR-eg (Y
axis) and PCR-de (X axis) were determined by Prism software. R
squared value was 0.35. Figure S5, Secondary structure of RPA
primers. Structures were created by Visual OMP program ((DNA
software, MI, USA). A, F02: B, F15; C, F04; D, R02; E, R06; F,
R20. Figure S6, Primer hybridizing to the FMDV standard DNA
affects its secondary structure. Structures were created by Visual
OMP program ((DNA software, MI, USA). A, FMDV standard
negative sense strand (7839–8098 of Genbank accession number
JF749843) in unhybridized form: B, hybridized with F04; C, with
F08; D, with R20. Primers are in black squares. Table S1,
Detection of FMDV in samples from infected animals during the
FMDV outbreak Egypt 2012 using real-time RT-PCR and RT-
RPA. Table S2, GC content of the RPA forward and reverse
primers.
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